<DOC>
	<DOC>NCT01916967</DOC>
	<brief_summary>This is a study to evaluate the efficacy and safety of desloratadine (MK-4117) in Japanese participants with chronic urticaria. The primary hypothesis is that the efficacy of desloratadine 10 mg and 5 mg is superior to placebo as based on the change from Baseline in the sum score of pruritus/itch and rash as assessed by the Investigator at Week 2.</brief_summary>
	<brief_title>An Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Chronic Urticaria (MK-4117-201)</brief_title>
	<detailed_description />
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Histamine</mesh_term>
	<mesh_term>Desloratadine</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<mesh_term>Histamine H1 Antagonists, Non-Sedating</mesh_term>
	<mesh_term>Histamine H1 Antagonists</mesh_term>
	<criteria>Chronic urticaria [rash (erythema, wheal) for more than 1 month without any known cause] Outpatient Stimulationinduced urticaria [physical urticaria (e.g. cold, solar, and heat urticaria), cholinergic urticaria, contact urticaria)] Hypersensitivity to antihistamines or ingredients of a study drug</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Urticaria</keyword>
	<keyword>Skin Diseases, Vascular</keyword>
	<keyword>Skin Diseases</keyword>
	<keyword>Hypersensitivity, Immediate</keyword>
	<keyword>Hypersensitivity</keyword>
	<keyword>Immune System Diseases</keyword>
	<keyword>Cholinergic Antagonists</keyword>
	<keyword>Cholinergic Agents</keyword>
	<keyword>Neurotransmitter Agents</keyword>
	<keyword>Histamine H1 Antagonists, Non-Sedating</keyword>
	<keyword>Histamine H1 Antagonists</keyword>
	<keyword>Histamine Antagonists</keyword>
	<keyword>Histamine Agents</keyword>
</DOC>